FFA
TTNP

Farther Finance Advisors’s Titan Pharmaceuticals TTNP Stock Holding History

Farther Finance Advisors’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 5974
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 5750

Other funds holding TTNP

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Farther Finance Advisors's TTNP Position: Q2 2026 in Review

Farther Finance Advisors held its Titan Pharmaceuticals (TTNP) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5974.

Farther Finance Advisors first reported a position in TTNP in Q1 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold TTNP as of Q2 2026.

  • Farther Finance Advisors held 1 share of Titan Pharmaceuticals worth $1 as of Q2 2026.
  • Farther Finance Advisors left its Titan Pharmaceuticals share count unchanged in Q2 2026.
  • Titan Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5974 holding.
  • Farther Finance Advisors first reported a position in Titan Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 4 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.